-
Home
-
About PMI
- Welcome to PMI Science
- Our Standards
- Our Scientists
- Our Initiatives
- Interactive tour of the Cube
- Our Network
Latest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More -
Smoke-free approach
- What is harm reduction?
- Absence of combustion
- Nicotine
- The role of smoke-free products
- Tar
- Tobacco Regulation
Smoke-free approachOffering smoke-free alternatives to adult smokers is a sensible, complementary addition to existing tobacco control strategies.Read MoreLatest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More -
Research
- Our Scientific Approach
- Our Findings
- PMI Publications Library
- Literature Reviews
- Independent Studies
- Expert Reports
- Investigator initiated studies (IIS)
- Latest PMI Science Booklet
- Facts and figures on our smoke-free future
ResearchPMI is committed to sharing results as the development and scientific assessment of smoke-free products advance.Read MoreLatest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More -
Our Products
- Tobacco Heating System
- Oven Heating System
- MESH Vaping System
- Disposable Vaping System
- Oral Nicotine Pouches
- Nicotine salts product
Our ProductsPMI believes that offering a range of smoke-free alternatives is essential to ensure individual smokers are able to find a smoke-free product that they can fully switch to.Read MoreLatest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More -
News & Events
- Scientific Update Magazine
- Open Science Events
- News
- Conferences Calendar
- Media Library
News & EventsRead our most recent articles and catch up on our latest events and conference presentations.Read MoreLatest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More - Contact Us
-
About PMI
Quantitative Proteomics to Investigate the Effects of a Prototype Modified Risk Tobacco Product (pMRTP) and Smoking Cessation on Mouse Lung Proteome
No abstract available.
Effects of aerosol from the Tobacco Heating System (THS) on human organotypic cultures of the aerodigestive tract
Systems Toxicology In ApoE-/- Mice Demonstrates Smoking Cessation Benefits For Both Cardiovascular And Lung Disease-Related Endpoints
Sytems toxicological-based assessment of sex-related differences in response to cigarette smoke within an OECD rat inhalation study
Quantitative Proteomics to Investigate the Effects of a Prototype Modified Risk Tobacco Product (pMRTP) and Smoking Cessation on Mouse Lung Proteome
Systems Toxicology Approaches Enable Mechanistic Comparison Of Cigarette Smoke-Induced And Spontaneous Lung Tumors In The A/J Mouse Model
Physiologically based Pharmacokinetic Modeling of Nicotine from Inhaled Aqueous Aerosol Predicts Marked Gastrointestinal Absorption in Rats
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.